Foamix Pharmaceuticals logo — company profile

Foamix Pharmaceuticals

Founded 2003 Israel Israel 31 employees Post Ipo Debt Health Care, Pharmaceutical

General Information

Company Name Foamix Pharmaceuticals
Founded Year 2003
Location Israel Israel +2
Employees 31
Industries Health Care, Pharmaceutical
Funding Stage Post Ipo Debt
Social

Get notified when Foamix Pharmaceuticals moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Foamix Pharmaceuticals

Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX) is a clinical stage specialty pharmaceutical company founded in 2003, headquartered in Israel. The company is dedicated to developing and commercializing proprietary topical foams to address unmet needs in dermatology. Their innovative product candidates include FMX101, a novel minocycline foam designed for the treatment of moderate-to-severe acne, and FMX103 for the treatment of moderate-to-severe rosacea. With a focus on the Health Care and Pharmaceutical industries, Foamix Pharmaceuticals is positioned to make a significant impact in addressing dermatological concerns. As of now, there is no available information on their last investment or investors.

No funding data available for Foamix Pharmaceuticals yet.

Get notified when Foamix Pharmaceuticals raises funding

Foamix Pharmaceuticals Alternatives & Competitors

Foamix Pharmaceuticals vs

Pioneering new frontiers in allergy treatment with breakthrough CRTH2 antagonists.

Series Unknown
Biotechnology, Life Sciences
Foamix Pharmaceuticals vs

A clinical-stage immunology focused biopharmaceutical company.

Post Ipo Equity
44 employees
Biotechnology, Health Care
Foamix Pharmaceuticals vs

Bringing healthcare solutions to the world

27 employees
Also compare with: Foamix Pharmaceuticals vs ImageneBio ImageneBio

FAQ About Foamix Pharmaceuticals

Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX), a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary topical foams to address unmet needs in dermatology. Our clinical stage product candidates include FMX101, our novel minocycline foam for the treatment...
Foamix Pharmaceuticals was founded in 2003.
Foamix Pharmaceuticals is headquartered in Israel.
Foamix Pharmaceuticals operates in the following industries: Health Care, Pharmaceutical.
Foamix Pharmaceuticals has approximately 31 employees.
Top alternatives and competitors to Foamix Pharmaceuticals include Atopix Therapeutics, ASLAN Pharmaceuticals, Nutra Pharma Corporation, ImageneBio, Sublimity Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Foamix Pharmaceuticals and Atopix Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Foamix Pharmaceuticals and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy